| 000 | 01679 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250512023858.0 | ||
| 264 | 0 | _c19880623 | |
| 008 | 198806s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(88)92009-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSteel, C M | |
| 245 | 0 | 0 |
_aHLA haplotype A1 B8 DR3 as a risk factor for HIV-related disease. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cMay 1988 |
||
| 300 |
_a1185-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Viral _xanalysis |
| 650 | 0 | 4 | _aDrug Contamination |
| 650 | 0 | 4 |
_aFactor VIII _xtherapeutic use |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHIV _xgenetics |
| 650 | 0 | 4 | _aHIV Antibodies |
| 650 | 0 | 4 |
_aHIV Seropositivity _xcomplications |
| 650 | 0 | 4 |
_aHLA Antigens _xgenetics |
| 650 | 0 | 4 | _aHLA-A1 Antigen |
| 650 | 0 | 4 | _aHLA-B8 Antigen |
| 650 | 0 | 4 |
_aHLA-D Antigens _xgenetics |
| 650 | 0 | 4 |
_aHLA-DR Antigens _xgenetics |
| 650 | 0 | 4 | _aHLA-DR3 Antigen |
| 650 | 0 | 4 | _aHaplotypes |
| 650 | 0 | 4 |
_aHemophilia A _ximmunology |
| 650 | 0 | 4 | _aHistocompatibility Testing |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aT-Lymphocytes _xclassification |
| 700 | 1 | _aLudlam, C A | |
| 700 | 1 | _aBeatson, D | |
| 700 | 1 | _aPeutherer, J F | |
| 700 | 1 | _aCuthbert, R J | |
| 700 | 1 | _aSimmonds, P | |
| 700 | 1 | _aMorrison, H | |
| 700 | 1 | _aJones, M | |
| 773 | 0 |
_tLancet (London, England) _gvol. 1 _gno. 8596 _gp. 1185-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(88)92009-0 _zAvailable from publisher's website |
| 999 |
_c2902852 _d2902852 |
||